Declining System Sales Drag Cepheid Q1 Revenues Down 13 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Cepheid reported on Thursday afternoon that its first-quarter revenue fell 13 percent year over year, largely due to a 45 percent drop in system sales.

The firm brought in revenues of $38.8 million for the three-month period ended March 31, compared to revenues of $44.8 million in the first quarter of 2008.

System sales dropped to $7.9 million from $14.3 million year over year, while sales of reagents and disposables increased 4 percent to $28.7 million from $27.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.